Part 201—Labeling

1. CFR
2. ›
3. Title 21
4. ›
5. Chapter I
6. ›
7. Part 201

Contents

• A
  Subpart A—General Labeling Provisions Sections 201.1–201.26
• Appendix A to Part 201
  Appendix A to Part 201—Examples of Graphic Enhancements Used by FDA
• B
  Subpart B—Labeling Requirements for Prescription Drugs and/or Insulin Sections 201.50–201.58
• C
  Subpart C—Labeling Requirements for Over-the-Counter Drugs Sections 201.60–201.80
• D
  Subpart D—Exemptions From Adequate Directions for Use Sections 201.100–201.130
• E
  Subpart E—Other Exemptions Sections 201.150–201.161
• F
  Subpart F—Labeling Claims for Drugs in Drug Efficacy Study Section 201.200
• G
  Subpart G—Specific Labeling Requirements for Specific Drug Products Sections 201.300–201.328